Strontium ranelate for the prevention of nonvertebral fracture in women with postmenopausal osteoporosis

Trial Profile

Strontium ranelate for the prevention of nonvertebral fracture in women with postmenopausal osteoporosis

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Oct 2013

At a glance

  • Drugs Strontium ranelate (Primary)
  • Indications Fracture; Postmenopausal osteoporosis
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms TROPOS
  • Most Recent Events

    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top